{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:25:17Z","timestamp":1783182317552,"version":"3.54.6"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,6]]},"DOI":"10.7759\/cureus.89494","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T17:09:16Z","timestamp":1754500156000},"source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness and Safety of Risankizumab for Psoriasis in a Liver Transplant Patient With Recurrent Metastatic Hepatocellular Carcinoma"],"prefix":"10.7759","author":[{"given":"Sandy","family":"Sylvain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Silvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Bainaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerforne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Masson Regnault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1373737","article-title":"Psoriasis in solid organ transplant patients: best practice recommendations from the Medical Board of the National Psoriasis Foundation","volume":"29","author":"Prussick R","year":"2018","unstructured":"Prussick R, Wu JJ, Armstrong AW, Siegel MP, Van Voorhees AS. Psoriasis in solid organ transplant patients: best practice recommendations from the Medical Board of the National Psoriasis Foundation. J Dermatolog Treat. 2018, 29:329-33. 10.1080\/09546634.2017.1373737","journal-title":"J Dermatolog Treat"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2022.11.004","article-title":"Case series: psoriasis in solid organ transplant patients and immunobiological agents","volume":"98","author":"Meneghello LP","year":"2023","unstructured":"Meneghello LP, Schulz DG, da Costa LP, de Carvalho AV. Case series: psoriasis in solid organ transplant patients and immunobiological agents. An Bras Dermatol. 2023, 98:678-81. 10.1016\/j.abd.2022.11.004","journal-title":"An Bras Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2023.09.023","article-title":"Risankizumab in the management of psoriasis in solid organ transplant recipients","volume":"115","author":"Luz M","year":"2024","unstructured":"Luz M, L\u00e9 AM, Torres T. Risankizumab in the management of psoriasis in solid organ transplant recipients. Actas Dermosifiliogr. 2024, 115:1070-2. 10.1016\/j.ad.2023.09.023","journal-title":"Actas Dermosifiliogr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18502\/ijaai.v17i4.89","article-title":"Evaluation of interleukin-21, 23 and 27 mRNA expression and protein level in liver transplant patients","volume":"17","author":"Afshari A","year":"2018","unstructured":"Afshari A, Yaghobi R, Azarpira N, Zadeh BG, Hosseini SA, Darbouy M, Karimi MH. Evaluation of interleukin-21, 23 and 27 mRNA expression and protein level in liver transplant patients. Iran J Allergy Asthma Immunol. 2018, 17:298-307. 10.18502\/ijaai.v17i4.89","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20818","article-title":"Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis","volume":"186","author":"Gordon KB","year":"2022","unstructured":"Gordon KB, Lebwohl M, Papp KA, et al.. Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis. Br J Dermatol. 2022, 186:466-75. 10.1111\/bjd.20818","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19603","article-title":"Biologics in psoriatic patients with malignancies: where are we now? An Italian multicentric study","volume":"38","author":"Magnano M","year":"2024","unstructured":"Magnano M, Balestri R, Gisondi P, et al.. Biologics in psoriatic patients with malignancies: where are we now? An Italian multicentric study. J Eur Acad Dermatol Venereol. 2024, 38:e331-4. 10.1111\/jdv.19603","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3994","article-title":"Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases","volume":"71","author":"Teng MW","year":"2011","unstructured":"Teng MW, von Scheidt B, Duret H, Towne JE, Smyth MJ. Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases. Cancer Res. 2011, 71:2077-86. 10.1158\/0008-5472.CAN-10-3994","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2015.09.012","article-title":"Use of etanercept for psoriasis in a liver transplant recipient","volume":"1","author":"Madankumar R","year":"2015","unstructured":"Madankumar R, Teperman LW, Stein JA. Use of etanercept for psoriasis in a liver transplant recipient. JAAD Case Rep. 2015, 1:S36-7. 10.1016\/j.jdcr.2015.09.012","journal-title":"JAAD Case Rep"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2012.09.008","article-title":"Treatment of severe psoriasis with etanercept in a pancreas-kidney transplant recipient","volume":"44","author":"Brokalaki EI","year":"2012","unstructured":"Brokalaki EI, Voshege N, Witzke O, Kribben A, Schadendorf D, Hillen U. Treatment of severe psoriasis with etanercept in a pancreas-kidney transplant recipient. Transplant Proc. 2012, 44:2776-7.","journal-title":"Transplant Proc"},{"key":"ref10","article-title":"Etanercept therapy for severe plaque psoriasis in a patient who underwent a liver transplant","volume":"80","author":"Hoover WD","year":"2007","unstructured":"Hoover WD. Etanercept therapy for severe plaque psoriasis in a patient who underwent a liver transplant. Cutis. 2007, 80:211-4.","journal-title":"Cutis"},{"key":"ref11","article-title":"Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant","volume":"27","author":"Collazo MH","year":"2008","unstructured":"Collazo MH, Gonz\u00e1lez JR, Torres EA. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant. P R Health Sci J. 2008, 27:346-7.","journal-title":"P R Health Sci J"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ad.2018.07.013","article-title":"Etanercept for psoriasis in a renal transplant recipient","volume":"111","author":"Garc\u00eda-Zamora E","year":"2020","unstructured":"Garc\u00eda-Zamora E, G\u00f3mez de la Fuente E, Mi\u00f1ano-Medrano R, et al.. Etanercept for psoriasis in a renal transplant recipient. Actas Dermosifiliogr. 2020, 111:169-71.","journal-title":"Actas Dermosifiliogr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0300060515593250","article-title":"Treatment of psoriasis with etanercept in immunocompromised patients: two case reports","volume":"44","author":"De Simone C","year":"2016","unstructured":"De Simone C, Perino F, Caldarola G, D'Agostino M, Peris K. Treatment of psoriasis with etanercept in immunocompromised patients: two case reports. J Int Med Res. 2016, 44:67-71. 10.1177\/0300060515593250","journal-title":"J Int Med Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14292","article-title":"Use of biologics for psoriasis in solid organ transplant recipients","volume":"65","author":"Blasco MC","year":"2024","unstructured":"Blasco MC, Doyle C, Diong S, Raghallaigh SN. Use of biologics for psoriasis in solid organ transplant recipients. Australas J Dermatol. 2024, 65:276-9. 10.1111\/ajd.14292","journal-title":"Australas J Dermatol"},{"key":"ref15","article-title":"Biologic treatment of psoriasis in solid organ transplant recipients","volume":"22","author":"Guglielmo A","year":"2024","unstructured":"Guglielmo A, Pileri A, Toniutto P, et al.. Biologic treatment of psoriasis in solid organ transplant recipients. J Dtsch Dermatol Ges J Ger Soc Dermatol. 2024, 22:283-7.","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13568","article-title":"Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: a case report","volume":"62","author":"Richetta A","year":"2021","unstructured":"Richetta A, Marraffa F, Grassi S, Aquila E, Dybala A, Aprile F, Merli M. Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: a case report. Australas J Dermatol. 2021, 62:e442-3. 10.1111\/ajd.13568","journal-title":"Australas J Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.12788\/cutis.0167","article-title":"Brodalumab in an organ transplant recipient with psoriasis","volume":"107","author":"Singh I","year":"2021","unstructured":"Singh I, Uy A, Kassardjian A, Armstrong AW. Brodalumab in an organ transplant recipient with psoriasis. Cutis. 2021, 107:104-6.","journal-title":"Cutis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2022.11.010","article-title":"Biotherapies for chronic inflammatory dermatosis in organ transplant recipients: 3 case reports and a literature review","volume":"150","author":"Matca\u015fu I","year":"2023","unstructured":"Matca\u015fu I, Haddad N, Barrou B, Conti F, Barete S. Biotherapies for chronic inflammatory dermatosis in organ transplant recipients: 3 case reports and a literature review. Ann Dermatol Venereol. 2023, 150:219-22. 10.1016\/j.annder.2022.11.010","journal-title":"Ann Dermatol Venereol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12909","article-title":"Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection","volume":"32","author":"Lora V","year":"2019","unstructured":"Lora V, Graceffa D, De Felice C, Morrone A, Bonifati C. Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection. Dermatol Ther. 2019, 32:e12909. 10.1111\/dth.12909","journal-title":"Dermatol Ther"},{"key":"ref20","article-title":"Use of anti-IL 17A for psoriasis is not necessarily contraindicated in organ transplantation patients","volume":"30","author":"Di Altobrando A","year":"2020","unstructured":"Di Altobrando A, Lacava R, Patrizi A, Sacchelli L, La Manna G, Comai G, Bardazzi F. Use of anti-IL 17A for psoriasis is not necessarily contraindicated in organ transplantation patients. Eur J Dermatol. 2020, 30:311-3.","journal-title":"Eur J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/377233-effectiveness-and-safety-of-risankizumab-for-psoriasis-in-a-liver-transplant-patient-with-recurrent-metastatic-hepatocellular-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T17:09:17Z","timestamp":1754500157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/377233-effectiveness-and-safety-of-risankizumab-for-psoriasis-in-a-liver-transplant-patient-with-recurrent-metastatic-hepatocellular-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.89494","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}